UCH-L5 Antibodies

Santa Cruz Biotechnology offers a broad range of UCH-L5 monoclonal antibodies for various research applications. UCH-L5 Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UCH-L5, also known as ubiquitin C-terminal hydrolase L5, plays a central role in the ubiquitin-proteasome system, which is essential for protein degradation and regulation within the cell. UCH-L5 participates in various cellular processes, including cell cycle regulation, DNA repair, and response to oxidative stress, making it significant in both normal physiology and disease states. Research has shown that UCH-L5 activity influences the development of cancer and neurodegenerative disorders. Scientists worldwide utilize UCH-L5 monoclonal antibodies to advance their understanding of cellular mechanisms and pathways. Investigating UCH-L5 function continues to reveal new insights into disease progression and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers to conduct precise and reliable experiments that contribute to advancing scientific knowledge and therapeutic development.